• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

谷氨酰胺酶2负向调节PI3K/AKT信号通路,并在人肝细胞癌中显示出肿瘤抑制活性。

Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma.

作者信息

Liu Juan, Zhang Cen, Lin Meihua, Zhu Wei, Liang Yingjian, Hong Xuehui, Zhao Yuhan, Young Ken H, Hu Wenwei, Feng Zhaohui

机构信息

Department of Radiation Oncology.

出版信息

Oncotarget. 2014 May 15;5(9):2635-47. doi: 10.18632/oncotarget.1862.

DOI:10.18632/oncotarget.1862
PMID:24797434
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4058033/
Abstract

The tumor suppressor p53 and its signaling pathway play a critical role in tumor prevention. As a direct p53 target gene, the role of glutaminase 2 (GLS2) in tumorigenesis is unclear. In this study, we found that GLS2 expression is significantly decreased in majority of human hepatocellular carcinoma (HCC). Restoration of GLS2 expression in HCC cells inhibits the anchorage-independent growth of cells and reduces the growth of HCC xenograft tumors. Interestingly, we found that GLS2 negatively regulates the PI3K/AKT signaling, which is frequently activated in HCC. Blocking the PI3K/AKT signaling in HCC cells largely abolishes the inhibitory effect of GLS2 on the anchorage-independent cell growth and xenograft tumor growth. The GLS2 promoter is hypermethylated in majority of HCC samples. CpG methylation of GLS2 promoter inhibits GLS2 transcription, whereas reducing the methylation of GLS2 promoter induces GLS2 expression. Taken together, our results demonstrate that GLS2 plays an important role in tumor suppression in HCC, and the negative regulation of PI3K/AKT signaling contributes greatly to this function of GLS2. Furthermore, hypermethylation of GLS2 promoter is an important mechanism contributing to the decreased GLS2 expression in HCC.

摘要

肿瘤抑制因子p53及其信号通路在肿瘤预防中发挥着关键作用。作为p53的直接靶基因,谷氨酰胺酶2(GLS2)在肿瘤发生中的作用尚不清楚。在本研究中,我们发现大多数人类肝细胞癌(HCC)中GLS2的表达显著降低。在HCC细胞中恢复GLS2表达可抑制细胞的非锚定依赖性生长,并减少HCC异种移植瘤的生长。有趣的是,我们发现GLS2负向调节PI3K/AKT信号通路,该信号通路在HCC中经常被激活。阻断HCC细胞中的PI3K/AKT信号通路在很大程度上消除了GLS2对非锚定依赖性细胞生长和异种移植瘤生长的抑制作用。大多数HCC样本中GLS2启动子发生高甲基化。GLS2启动子的CpG甲基化抑制GLS2转录,而降低GLS2启动子的甲基化则诱导GLS2表达。综上所述,我们的结果表明GLS2在HCC的肿瘤抑制中发挥重要作用,PI3K/AKT信号通路的负向调节对GLS2的这一功能有很大贡献。此外,GLS2启动子的高甲基化是导致HCC中GLS2表达降低的重要机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/988b/4058033/63762139aa0b/oncotarget-05-2635-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/988b/4058033/9652d910fb93/oncotarget-05-2635-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/988b/4058033/fd08707ddd61/oncotarget-05-2635-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/988b/4058033/a3a332dc76c0/oncotarget-05-2635-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/988b/4058033/a47096b980ad/oncotarget-05-2635-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/988b/4058033/5f36275db7cb/oncotarget-05-2635-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/988b/4058033/ab21a3394396/oncotarget-05-2635-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/988b/4058033/63762139aa0b/oncotarget-05-2635-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/988b/4058033/9652d910fb93/oncotarget-05-2635-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/988b/4058033/fd08707ddd61/oncotarget-05-2635-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/988b/4058033/a3a332dc76c0/oncotarget-05-2635-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/988b/4058033/a47096b980ad/oncotarget-05-2635-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/988b/4058033/5f36275db7cb/oncotarget-05-2635-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/988b/4058033/ab21a3394396/oncotarget-05-2635-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/988b/4058033/63762139aa0b/oncotarget-05-2635-g007.jpg

相似文献

1
Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma.谷氨酰胺酶2负向调节PI3K/AKT信号通路,并在人肝细胞癌中显示出肿瘤抑制活性。
Oncotarget. 2014 May 15;5(9):2635-47. doi: 10.18632/oncotarget.1862.
2
FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.FAM9C 通过激活人肝癌细胞中的 PI3K/Akt 通路发挥抗凋亡作用。
Oncol Rep. 2013 Sep;30(3):1275-84. doi: 10.3892/or.2013.2592. Epub 2013 Jul 5.
3
MicroRNA-105 suppresses cell proliferation and inhibits PI3K/AKT signaling in human hepatocellular carcinoma.微小 RNA-105 抑制人肝癌细胞增殖并抑制 PI3K/AKT 信号通路。
Carcinogenesis. 2014 Dec;35(12):2748-55. doi: 10.1093/carcin/bgu208. Epub 2014 Oct 3.
4
DNA methylation-mediated silencing of Neuronatin promotes hepatocellular carcinoma proliferation through the PI3K-Akt signaling pathway.DNA 甲基化介导的 Neuronatin 沉默通过 PI3K-Akt 信号通路促进肝癌增殖。
Life Sci. 2023 Jan 1;312:121266. doi: 10.1016/j.lfs.2022.121266. Epub 2022 Dec 5.
5
MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.微小RNA-155-5p通过PI3K/Akt信号通路抑制PTEN从而促进肝细胞癌进展。
Cancer Sci. 2017 Apr;108(4):620-631. doi: 10.1111/cas.13177. Epub 2017 Apr 19.
6
Methylation-regulated tumor suppressor gene PDE7B promotes HCC invasion and metastasis through the PI3K/AKT signaling pathway.甲基化调控的抑癌基因 PDE7B 通过 PI3K/AKT 信号通路促进 HCC 侵袭和转移。
BMC Cancer. 2024 May 22;24(1):624. doi: 10.1186/s12885-024-12364-w.
7
The silencing of Pokemon attenuates the proliferation of hepatocellular carcinoma cells in vitro and in vivo by inhibiting the PI3K/Akt pathway.沉默 Pokemon 可通过抑制 PI3K/Akt 通路来抑制肝癌细胞在体外和体内的增殖。
PLoS One. 2012;7(12):e51916. doi: 10.1371/journal.pone.0051916. Epub 2012 Dec 26.
8
EVA1A reverses lenvatinib resistance in hepatocellular carcinoma through regulating PI3K/AKT/p53 signaling axis.EVA1A 通过调节 PI3K/AKT/p53 信号轴逆转肝癌对乐伐替尼的耐药性。
Apoptosis. 2024 Aug;29(7-8):1161-1184. doi: 10.1007/s10495-024-01967-0. Epub 2024 May 14.
9
VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR-PI3K-AKT pathway.聚糖 V1 通过激活 EGFR-PI3K-AKT 通路促进肝癌的增殖和转移。
Oncogene. 2020 Feb;39(6):1213-1230. doi: 10.1038/s41388-019-1052-7. Epub 2019 Oct 11.
10
PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway.PTEN 通过协调降低 MMP 表达来抑制 HepG2 细胞的迁移和侵袭,途径是 PI3K/Akt 通路。
Oncol Rep. 2010 Jun;23(6):1593-600. doi: 10.3892/or_00000800.

引用本文的文献

1
UPLC-MS/MS Metabolomics Reveals Babao Dan's Mechanisms in MASH Treatment with Integrating Network Pharmacology and Molecular Docking.超高效液相色谱-串联质谱代谢组学结合网络药理学和分子对接揭示八宝丹治疗急性重症胰腺炎的机制
Pharmaceuticals (Basel). 2025 Jul 25;18(8):1111. doi: 10.3390/ph18081111.
2
Metabolic reprogramming in hepatocellular carcinoma: mechanisms of immune evasion and therapeutic implications.肝细胞癌中的代谢重编程:免疫逃逸机制及治疗意义
Front Immunol. 2025 Apr 30;16:1592837. doi: 10.3389/fimmu.2025.1592837. eCollection 2025.
3
Metabolic reprogramming and immunological changes in the microenvironment of esophageal cancer: future directions and prospects.

本文引用的文献

1
Tumour-associated mutant p53 drives the Warburg effect.肿瘤相关突变型 p53 驱动瓦博格效应。
Nat Commun. 2013;4:2935. doi: 10.1038/ncomms3935.
2
Hepatocellular carcinoma.肝细胞癌。
Lancet. 2012 Mar 31;379(9822):1245-55. doi: 10.1016/S0140-6736(11)61347-0. Epub 2012 Feb 20.
3
DNA methylation detection: bisulfite genomic sequencing analysis.DNA甲基化检测:亚硫酸氢盐基因组测序分析。
食管癌微环境中的代谢重编程与免疫变化:未来方向与前景
Front Immunol. 2025 Jan 24;16:1524801. doi: 10.3389/fimmu.2025.1524801. eCollection 2025.
4
GLS2 reduces the occurrence of epilepsy by affecting mitophagy function in mouse hippocampal neurons.GLS2 通过影响小鼠海马神经元的线粒体自噬功能减少癫痫的发生。
CNS Neurosci Ther. 2024 Oct;30(10):e70036. doi: 10.1111/cns.70036.
5
Targeting amino acid-metabolizing enzymes for cancer immunotherapy.针对氨基酸代谢酶的癌症免疫疗法。
Front Immunol. 2024 Aug 14;15:1440269. doi: 10.3389/fimmu.2024.1440269. eCollection 2024.
6
CD87-targeted BiTE and CAR-T cells potently inhibit invasive nonfunctional pituitary adenomas.CD87 靶向 BiTE 和 CAR-T 细胞能有效抑制侵袭性无功能垂体腺瘤。
Sci China Life Sci. 2024 Oct;67(10):2169-2185. doi: 10.1007/s11427-024-2591-7. Epub 2024 Jul 8.
7
Glutaminase - A potential target for cancer treatment.谷氨酰胺酶——癌症治疗的一个潜在靶点。
Biomedicine (Taipei). 2024 Jun 1;14(2):29-37. doi: 10.37796/2211-8039.1445. eCollection 2024.
8
Elucidating the chain of command: our current understanding of critical target genes for p53-mediated tumor suppression.阐明指挥链:我们目前对 p53 介导的肿瘤抑制的关键靶基因的理解。
Crit Rev Biochem Mol Biol. 2024 Feb-Apr;59(1-2):128-138. doi: 10.1080/10409238.2024.2344465. Epub 2024 Apr 25.
9
Ferroptosis in hepatocellular carcinoma, from mechanism to effect.肝细胞癌中的铁死亡:从机制到影响
Front Oncol. 2024 Mar 5;14:1350011. doi: 10.3389/fonc.2024.1350011. eCollection 2024.
10
Exploiting the Achilles' heel of cancer: disrupting glutamine metabolism for effective cancer treatment.利用癌症的阿喀琉斯之踵:破坏谷氨酰胺代谢以实现有效的癌症治疗。
Front Pharmacol. 2024 Mar 6;15:1345522. doi: 10.3389/fphar.2024.1345522. eCollection 2024.
Methods Mol Biol. 2011;791:11-21. doi: 10.1007/978-1-61779-316-5_2.
4
Global cancer statistics.全球癌症统计数据。
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.
5
CNV analysis using TaqMan copy number assays.使用TaqMan拷贝数检测法进行拷贝数变异(CNV)分析。
Curr Protoc Hum Genet. 2010 Oct;Chapter 2:Unit2.13. doi: 10.1002/0471142905.hg0213s67.
6
Gene Amplifications in Well-Differentiated Pancreatic Neuroendocrine Tumors Inactivate the p53 Pathway.高分化胰腺神经内分泌肿瘤中的基因扩增使p53通路失活。
Genes Cancer. 2010 May 15;1(4):360-368. doi: 10.1177/1947601910371979.
7
Negative regulation of tumor suppressor p53 by microRNA miR-504.肿瘤抑制因子 p53 受 microRNA miR-504 的负调控。
Mol Cell. 2010 Jun 11;38(5):689-99. doi: 10.1016/j.molcel.2010.05.027.
8
The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein.p53 蛋白对能量代谢和 IGF-1/mTOR 通路的调节作用。
Trends Cell Biol. 2010 Jul;20(7):427-34. doi: 10.1016/j.tcb.2010.03.004.
9
Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function.谷氨酰胺酶 2:一种新的 p53 靶基因,调节能量代谢和抗氧化功能。
Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7455-60. doi: 10.1073/pnas.1001006107. Epub 2010 Apr 8.
10
Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species.磷酸化谷氨酰胺酶(GLS2),一种 p53 诱导的谷氨酰胺代谢和活性氧调节因子。
Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7461-6. doi: 10.1073/pnas.1002459107. Epub 2010 Mar 29.